Results 61 to 70 of about 13,322 (172)

A Decade of the Global STI Vaccine Roadmap: Progress, Gaps and Challenges

Journal of the International AIDS Society, Volume 29, Issue S2, July 2026.
Remco P. H. Peters, Sinead Delany‐Moretlwe, Kate L. Seib, Birgitte Giersing, Sami L. Gottlieb   +4 more
wiley   +1 more source

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

Infection and Drug Resistance, 2014
Carine P Hedari,* Rima W Khinkarly,* Ghassan S Dbaibo Center for Infectious Diseases Research, Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon ...
Hedari CP, Khinkarly RW, Dbaibo GS
doaj  

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3

Биопрепараты: Профилактика, диагностика, лечение, 2018
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also ...
M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya   +2 more
doaj  

Meningococcal vaccine information on YouTube in Türkiye: A cross-sectional analysis of content quality and reliability

Human Vaccines & Immunotherapeutics
Meningococcal infections represent a significant public health concern due to their high mortality and morbidity rates. In Turkey, meningococcal vaccines are not included in the routine immunization schedule, and families increasingly seek health-related
Ayse Esra Tapci, Oguzhan Serin, Medine Aysin Tasar   +2 more
doaj   +1 more source

Meningococcal conjugate vaccines: optimizing global impact

Infection and Drug Resistance, 2011
Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, 2Meningitis and Vaccine Preventable Diseases Branch, National Center for ...
Terranella A, Cohn A, Clark T
doaj  

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease

Expert Review of Vaccines
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde, Chiranjiwi Bhusal, Catherine A. Cosgrove, Woo-Yun Sohn   +3 more
doaj   +1 more source

Impact of meningococcal group B OMV vaccines, beyond their brief

Human Vaccines & Immunotherapeutics, 2018
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity.
Helen Petousis-Harris
doaj   +1 more source

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

Journal of Immunology Research, 2015
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini, D. Panatto, N. L. Bragazzi, P. L. Lai, A. Bechini, M. Levi, P. Durando, D. Amicizia   +7 more
doaj   +1 more source

Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel), 2023
Conti A, Broglia G, Sacchi C, Risi F, Barone-Adesi F, Panella M.   +5 more
europepmc   +1 more source

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. [PDF]

Am J Epidemiol, 2022
Prunas O, Weinberger DM, Medini D, Tizzoni M, Argante L.   +4 more
europepmc   +1 more source